During the past decade, Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie" #1 collaborator was "Celgene Corporation" with 1 trials as a collaborator, "Celltrion Healthcare Co., LTD" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "X-act Cologne Clinical Research GmbH" with 1 trials as a collaborator and "Zentrum für Klinische Studien Ulm" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie" are "Anemia" (1 trials), "Marginal Zone Lymphoma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie" in a lesser frequency.

Most popular intervention types in "Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Luspatercept Injection" (1 trials), "Pembrolizumab" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken Maria Hilf GmbH Klinik für Hämatologie, Onkologie und Gastroenterologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".